Literature DB >> 24663391

[Differential diagnose of angioedema. Acute edematous scleromyxedema].

S Gerstner1, H Kneitz, E-B Bröcker, A Trautmann.   

Abstract

A woman presented in the emergency room with the diagnosis of angioedema refractory to treatment. She had soft, compressible periorbital edema, as well as edema of her hands and lower arms. She also complained of severe pain in her hands including sensations of numbness and tingling. The history, course and examination results eliminated several possible differential diagnostic considerations like an acute histamine- or bradykinin-mediated angioedema or superior vena cava syndrome. Histological examination confirmed the diagnosis of scleromyxedema.

Entities:  

Mesh:

Year:  2014        PMID: 24663391     DOI: 10.1007/s00105-013-2724-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  26 in total

Review 1.  Scleromyxedema.

Authors:  Clara-Dina Cokonis Georgakis; Gerald Falasca; Alexander Georgakis; Warren R Heymann
Journal:  Clin Dermatol       Date:  2006 Nov-Dec       Impact factor: 3.541

Review 2.  Fever, convulsions and coma in scleromyxedema: a "dermato-neuro syndrome".

Authors:  Y River; I Levy; L Gilead; H Orbach; Y Almog
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

3.  Stimulation of fibroblasts by paraprotein in scleromyxedema.

Authors:  G M White; E W Jeffes
Journal:  J Am Acad Dermatol       Date:  1989-10       Impact factor: 11.527

4.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 5.  Scleromyxedema myopathy: case report and review of the literature.

Authors:  D J Helfrich; E R Walker; A J Martinez; T A Medsger
Journal:  Arthritis Rheum       Date:  1988-11

6.  Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients.

Authors:  Franco Rongioletti; Giulia Merlo; Elisa Cinotti; Valentina Fausti; Emanuele Cozzani; Bernard Cribier; Dieter Metze; Eduardo Calonje; Jean Kanitakis; Werner Kempf; Catherine M Stefanato; Eduardo Marinho; Aurora Parodi
Journal:  J Am Acad Dermatol       Date:  2013-02-26       Impact factor: 11.527

7.  Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.

Authors:  M P Binitha; G Nandakumar; Daisy Thomas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 May-Jun       Impact factor: 2.545

8.  Lichen myxedematosus (scleromyxedema) serum stimulates hyaluronic acid and prostaglandin E production by human fibroblasts.

Authors:  M Yaron; I Yaron; I Yust; S Brenner
Journal:  J Rheumatol       Date:  1985-02       Impact factor: 4.666

9.  Scleromyxedema.

Authors:  A M Dinneen; C H Dicken
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

Review 10.  The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis).

Authors:  G F Webster; L Y Matsuoka; D Burchmore
Journal:  J Am Acad Dermatol       Date:  1993-01       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.